SCHEMBL25538787

SCHEMBL25538787

CC1(C)c2cc(-c3ccc(-c4nc(-c5ccccc5)cc(-c5ccccc5-c5ccccc5)n4)c4ccccc34)ccc2-c2cc3ccccc3cc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACACA Q13085 3/20 0.39
MEN1 O00255 7/20 0.37
KMT2A Q03164 7/20 0.37
MAPT P10636 5/20 0.37
ALDH1A1 P00352 4/20 0.37
HPGD P15428 4/20 0.37
CYP1A1 P04798 1/20 0.35
CYP1B1 Q16678 1/20 0.35
RARB P10826 1/20 0.34
RARG P13631 1/20 0.34
RXRA P19793 1/20 0.34
NTSR1 P30989 1/20 0.34
ENPP3 O14638 1/20 0.34
ENPP1 P22413 1/20 0.34
LMNA P02545 3/20 0.33
KDM4E B2RXH2 3/20 0.33
TDP1 Q9NUW8 2/20 0.33
GLA P06280 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25538792 0.99 ACACA (0.38) ACACAMEN1KMT2AMAPTALDH1A1
SCHEMBL25540203 0.99 ACACA (0.38) ACACAMEN1KMT2AMAPTALDH1A1
SCHEMBL25540371 0.99 ACACA (0.38) ACACAMEN1KMT2AMAPTALDH1A1
SCHEMBL25540057 0.97 ACACA (0.37) ACACAMEN1KMT2AMAPTALDH1A1
SCHEMBL25539897 0.97 ACACA (0.38) ACACAMEN1KMT2AMAPTALDH1A1
SCHEMBL25538816 0.95 CYP1A1 (0.41) ACACAMEN1KMT2AMAPTALDH1A1
SCHEMBL25539316 0.95 ACACA (0.38) ACACAMEN1KMT2AMAPTALDH1A1
SCHEMBL25540281 0.94 ACACA (0.37) ACACAMEN1KMT2AMAPTALDH1A1
SCHEMBL25539324 0.94 ACACA (0.37) ACACAMEN1KMT2AMAPTALDH1A1
SCHEMBL25538783 0.94 MEN1 (0.41) ACACAMEN1KMT2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM ACACA 1790/4885MEN1 267/4885KMT2A 1094/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.